Stress & Cortisol Reduction Study Analysis

Comprehensive analysis of the landmark study demonstrating ashwagandha's powerful stress-reducing and cortisol-lowering effects.

Analysis by MaryLyn L. & Liisa T. Last updated: January 2025

Study Overview

Study Details

  • Title: A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults
  • Authors: Chandrasekhar K, Kapoor J, Anishetty S
  • Journal: Indian Journal of Medical Research
  • Year: 2012
  • PubMed ID: 23125505

Key Results

  • Cortisol Reduction: 27.9% decrease
  • Stress Score Improvement: 44% reduction
  • Anxiety Reduction: Significant improvement
  • Safety: Well-tolerated with no adverse effects
  • Duration: 60 days

Study Background and Significance

This landmark study by Chandrasekhar and colleagues represents one of the most comprehensive and well-designed clinical trials examining ashwagandha's effects on stress and cortisol levels. Published in the prestigious Indian Journal of Medical Research, this research has become a cornerstone reference for ashwagandha's stress-reducing properties.

Study Design and Methodology

Participants

The study included 64 adults (aged 18-54 years) with a history of chronic stress. Participants were carefully screened to ensure they met specific stress criteria and were free from major medical conditions that could interfere with the results.

Study Design

  • Type: Randomized, double-blind, placebo-controlled trial
  • Duration: 60 days
  • Groups: Ashwagandha group (n=32) and placebo group (n=32)
  • Dosage: 300mg twice daily (600mg total daily dose)
  • Extract: High-concentration full-spectrum ashwagandha root extract

Outcome Measures

The researchers used multiple validated assessment tools:

  • Perceived Stress Scale (PSS): Standardized questionnaire measuring stress levels
  • Depression Anxiety Stress Scale (DASS-21): Comprehensive mood assessment
  • Serum Cortisol: Morning cortisol levels measured via blood tests
  • General Health Questionnaire (GHQ-28): Overall well-being assessment

Key Findings and Results

Cortisol Reduction

The most striking finding was the significant reduction in serum cortisol levels:

  • Ashwagandha group: 27.9% reduction in morning cortisol levels
  • Placebo group: No significant change
  • Statistical significance: p < 0.001, indicating extremely strong evidence

Perceived Stress Improvement

Participants taking ashwagandha experienced dramatic improvements in stress perception:

  • PSS scores: 44% improvement compared to baseline
  • Placebo comparison: Significantly better than placebo group
  • Clinical relevance: Improvements were both statistically and clinically significant

Anxiety and Mood Benefits

The DASS-21 assessment revealed significant improvements in:

  • Anxiety levels
  • Depression scores
  • Overall stress ratings
  • General psychological well-being

Safety and Tolerability

The study demonstrated excellent safety and tolerability:

  • Adverse events: No serious adverse events reported
  • Side effects: Minimal and comparable to placebo
  • Laboratory parameters: No clinically significant changes
  • Compliance: High participant compliance throughout the study

Clinical Implications

Mechanism of Action

The study's results support ashwagandha's classification as an adaptogen by demonstrating its ability to:

  • Normalize HPA (hypothalamic-pituitary-adrenal) axis function
  • Reduce excessive cortisol production
  • Improve stress resilience and adaptation
  • Support overall psychological well-being

Practical Applications

The findings suggest that ashwagandha supplementation may be beneficial for:

  • Individuals with chronic stress
  • People with elevated cortisol levels
  • Those seeking natural stress management solutions
  • Individuals with stress-related health concerns

Study Strengths

  • Rigorous design: Double-blind, placebo-controlled methodology
  • Objective measures: Biochemical cortisol testing alongside subjective assessments
  • Adequate duration: 60-day study period allows for meaningful adaptation
  • Validated tools: Use of standardized, validated assessment instruments
  • Statistical power: Sufficient sample size for meaningful conclusions

Limitations and Considerations

  • Population: Study focused on adults with chronic stress; results may vary in other populations
  • Duration: Long-term effects beyond 60 days were not assessed
  • Dosage: Only one dosage level was tested
  • Geographic scope: Single-center study in India

Conclusion

This landmark study provides compelling evidence for ashwagandha's effectiveness in reducing stress and cortisol levels. The 27.9% reduction in cortisol and 44% improvement in perceived stress represent clinically meaningful benefits that support ashwagandha's traditional use as an adaptogenic herb.

The study's rigorous methodology, significant results, and excellent safety profile make it a cornerstone reference for ashwagandha's stress-reducing properties. These findings have been replicated and extended by subsequent research, further validating ashwagandha's role in stress management.

Related Studies

Full Citation

Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Medical Research, 136(3), 404-411. PMID: 23125505. Available at: https://pubmed.ncbi.nlm.nih.gov/23125505/